You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Chronic Myeloid Leukemia

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Myeloid Malignancies, Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Houston (Cyclophosphamide, Mesna, Filgrastim)

Recruiting
  • Myeloid Malignancies
  • +3 more
  • Houston, Texas
    M D Anderson Caner Center
Nov 17, 2022

Acute Myeloid Leukemia, Acute Lymphoid Leukemia, Mixed Phenotype Acute Leukemia Trial in Gainesville (Orca-Q)

Recruiting
  • Acute Myeloid Leukemia
  • +6 more
  • Orca-Q
  • Gainesville, Florida
    University of Florida
Aug 26, 2022

Among CP-CML Participants Initiating Dasatinib inReal Life

Completed
  • Chronic Myeloid Leukemia
  • Non-Interventional
  • Paris, France
    Local Institution
Jun 17, 2022

Generic Imatinib Compared to Glivec® in Real-Life Management of

Not yet recruiting
  • Chronic Myeloid Leukemia
  • Cairo, Egypt
  • +1 more
Mar 16, 2022

Concomitant Medications at CML Diagnosis

Completed
  • Chronic Myeloid Leukemia
  • the prevalence of comorbid conditions
  • (no location specified)
Sep 16, 2023

Chronic Myeloid Leukemia, Chronic Phase Trial in Monterrey (Dasatinib Pill, Ketoconazole Pill)

Recruiting
  • Chronic Myeloid Leukemia, Chronic Phase
  • Dasatinib Pill
  • Ketoconazole Pill
  • Monterrey, Nuevo Leon, Mexico
    Hospital Universitario Dr. José Eleuterio González
Nov 25, 2022

Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Atypical Chronic Myeloid

Active, not recruiting
  • Acute Myeloid Leukemia
  • +9 more
  • Los Angeles, California
  • +5 more
Jan 27, 2023

New Diagnosed Chronic Phase Chronic Myeloid Leukemia

Recruiting
  • Validity and Safety
    • Guangzhou, Guangdong, China
      NanfangH
    Apr 9, 2022

    Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic

    Recruiting
    • Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
    • +2 more
    • Laboratory Biomarker Analysis
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jun 15, 2022

    CML, Chronic Phase Trial in Harbin (Flumatinib, Imatinib)

    Not yet recruiting
    • CML, Chronic Phase
    • Harbin, Heilongjiang, China
      Institute of Hematology and Oncology, Harbin The First Hospital
    May 5, 2022

    Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Chronic Phase Chronic Myelogenous Leukemia Trial in Philadelphia (Text

    Recruiting
    • Chronic Myelogenous Leukemia, BCR-ABL1 Positive
    • Chronic Phase Chronic Myelogenous Leukemia
    • Text Message-Based Navigation Intervention
    • Survey Administration
    • Philadelphia, Pennsylvania
      Sidney Kimmel Cancer Center at Thomas Jefferson University
    Apr 7, 2022

    3rd Line Therapy or More to Treat Adult CML- CP in Real World

    Not yet recruiting
    • Chronic Myeloid Leukemia
    • Asciminib
    • (no location specified)
    Oct 16, 2023

    CML (Chronic Myelogenous Leukemia Trial (KDS-1001)

    Not yet recruiting
    • CML (Chronic Myelogenous Leukemia
    • (no location specified)
    Jul 27, 2022

    Treatment Free Remission (TFR) in CML Patients (CML-CP)Study

    Not yet recruiting
    • Chronic Myeloid Leukemia
    • Treatment-free Remission
    • TFR(Treatment-Free Remission)
    • (no location specified)
    Jun 27, 2022

    Chronic Myeloid Leukemia Trial (Asciminib)

    Available
    • Chronic Myeloid Leukemia
    • (no location specified)
    Jan 17, 2023

    Chronic Myeloid Leukemia Trial in Saint-Étienne (Pharmaceutical intervention)

    Recruiting
    • Chronic Myeloid Leukemia
    • Pharmaceutical intervention
    • Saint-Étienne, France
      CHU de Saint-Etienne
    Feb 24, 2022

    Study Conducted Among Patients With CML

    Completed
    • Chronic Myeloid Leukemia
    • Tyrosine Kinase Inhibitors (TKIs)
    • East Hanover, New Jersey
      Novartis Investigative Site
    Jul 25, 2022

    Needs of 3L+ CP-CML and With T315I-mutated CML Patients

    Completed
    • Chronic Myeloid Leukemia
    • 3L Therapy
    • T315I
    • Lyon, France
      Novartis Investigative Site
    Nov 9, 2022

    Acute Biphenotypic Leukemia, Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial in

    Recruiting
    • Acute Biphenotypic Leukemia
    • +13 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jan 19, 2023

    Chronic Myeloid Leukemia Trial in New York (Nilotinib)

    Completed
    Has Results
    • Chronic Myeloid Leukemia
    • New York, New York
      Weill Cornell Medical College
    Mar 24, 2022

    Acute Myeloid Leukemia, MDS, Chronic Myelomonocytic Leukemia Trial in Rochester (Hyperbaric oxygen)

    Recruiting
    • Acute Myeloid Leukemia
    • +6 more
    • Hyperbaric oxygen
    • Rochester, New York
      Wilmot Cancer Institute, University of Rochester
    May 16, 2022

    Myeloproliferative Tumor, Chronic Phase Chronic Myelogenous Leukemia, Chronic Myeloid Leukemia Trial in San Francisco (Online

    Recruiting
    • Myeloproliferative Neoplasm
    • +2 more
    • Online Mindfulness Meditation
    • Internet-Based Webinars
    • San Francisco, California
      University of California San Francisco
    Aug 9, 2022

    Chronic Phase Chronic Myelogenous Leukemia Trial in Detroit, Milwaukee (Asciminib, Imatinib)

    Recruiting
    • Chronic Phase Chronic Myelogenous Leukemia
    • Detroit, Michigan
    • +1 more
    May 3, 2022

    CML, Chronic Phase Trial in Harbin (Flumatinib mesylate tablets (400mg), Flumatinib mesylate tablets (600mg))

    Recruiting
    • CML, Chronic Phase
    • Flumatinib mesylate tablets (400mg)
    • Flumatinib mesylate tablets (600mg)
    • Harbin, Hei Longjiang, China
      Institute of Hematology and Oncology, Harbin The First Hospital
    Apr 28, 2022

    Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive,

    Completed
    • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
    • +4 more
    • Eltrombopag Olamine
    • Houston, Texas
      M D Anderson Cancer Center
    Jan 4, 2022